Jonas Ide

Series-A Investments in Chemistry, Industrial Tech, Food Tech and Circularity

Frankfurt Rhine-Main Metropolitan Area

About

Venture Capital investor with deep expertise in the Chemical and Life Science industries. Over a decade of experience in a leading German chemical enterprise, with a global focus on biomaterials and drug delivery, strategic growth initiatives, and integration of acquired businesses. Passionate about science-based startups, deep tech innovations, and capex-light, scalable business models that transform industrial value chains. Currently part of the Oetker Collection KG, a family-owned group with €2.6 billion in revenues and around 8,300 employees across 148 companies in 37 countries, active in sparkling wine and spirits, bakery food, specialty chemicals, luxury hotels, real estate, venture capital, and art collection. Blending 130 years of tradition with modern entrepreneurial drive, the group stands for responsibility, long-term orientation, and innovation.

Experience

  • Investor & Board Observer at planetary
    Apr 2026 - Present · 3 mos

  • Senior Investment Manager - Venture & Growth Capital at Oetker Collection KG
    Jul 2025 - Present · 1 yr

    With a revenue of nearly €2.6 billion and almost 8,300 employees, Oetker Collection KG is an internationally active group owned by shareholders Dr. Alfred and Ferdinand Oetker. It comprises 148 individual companies in 37 countries. The business divisions of Oetker Collection include: Sparkling Wine, Wine & Spirits (Henkell Freixenet); Bakery Food (Martin Braun-Gruppe); Speciality Chemicals (Budenheim); Masterpiece Hotels (Oetker Hotels); Commercial Real Estate (Columbus Properties); Ventures (Vierte Oetker Ventures); and Art Collection (Rudolf-August Oetker Kunstsammlung).

  • Board Observer at Biograil™
    Jan 2022 - Jul 2025 · 3 yrs 7 mos

  • Investment Manager at Evonik Venture Capital
    May 2020 - Jul 2025 · 5 yrs 3 mos

    -> Manage fund finances, guide investment strategies, and track key performance metrics -> Oversee the active investment portfolio, devising strategies to optimize financial and strategic returns -> Source and manage investment opportunities within the European Healthcare sector -> Conduct due diligence and investment term negotiations

  • Evonik (15 yrs 8 mos)
    • Head of Marketing Health Care
      Jan 2016 - May 2020 · 4 yrs 5 mos

    • Global Product Manager Biomaterials
      May 2011 - Dec 2015 · 4 yrs 8 mos

    • Regional Manager SEA
      Jan 2009 - Apr 2011 · 2 yrs 4 mos